Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas

Auris Nasus Larynx

Volumn 24, Issue 2, 1997, Pages 193-198

  Arai, Yasuhiro ^a   Tsukuda, Mamoru ^b   Ito, Keiko ^b   Enomoto, Hiroyuki ^b   Furukawa, Madoka ^a   Kubota, Akira ^a   Yanoma, Syunsuke ^a   Okamoto, Naoyuki ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chemotherapy; DNA ploidy; Flow cytometry; Head and neck squamous cells

Indexed keywords

CISPLATIN; DNA; FLUOROURACIL;

ANEUPLOIDY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; DIPLOIDY; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLOIDY; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PLOIDIES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 0030980715     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(96)00018-1     Document Type: Article

References (18)

1. Atkin NB. Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br J Cancer 1979;40:210-221.
2. Atkin NB. Prognostic significance of ploidy level in human tumours II extra-uterine cancers and summary of data on 1171 tumours. Cytobios 1976;15:233-237.
3. Ulf KZ, Johan W, Sven BE, et al. Prognostic factors in head and neck cancer. Head Neck 1991;November/December:477-487.
4. Adel KE, Virginia LV, Mario AL, et al. Intratumoral DNA content heterogeneity in Laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1992;118:169-173.
5. John MT, Susan GF, Theodore EB, et al. DNA content and histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of larynx. Cancer 1992;70:56-62.
6. Troels B, Sorensen FB, Gaihede M, et al. Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas. Cancer 1992;70:1-13.
7. Lars EH. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope 1982;92:1064-1069.
8. Norman TB, Barbara NM, Neil EK. A comparison of flow cytometric DNA analyses of fresh and fixed squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 1987;113:1301-1306.
9. John HK, Greg B, Diana B, et al. Prognostic importance of cellular DNA content in head-and-neck squamous-cell cancers. Int J Cancer 1991;47:31-37.
10. Don LB, John RJ, Zosia M, et al. DNA ploidy and metastatic squamous cell head and neck cancers. Arch Otolaryngol Head Neck Surg 1992;118:185-187.
11. Kokal W. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region. Am J Surg 1988;156:276-280.
12. Sickle SB. Flow cytometric analysis of DNA content as a prognostic indicator in squamous cell carcinoma of the tongue. Am J Surg 1986;152:393-395.
13. Farrar W. Follow-up on flow cytometric DNA analysis of squamous cell carcinoma of the tongue. Am J Surg 1989;157:377-380.
14. Olli PK. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988;9:164-169.
15. Schutte B, Reynders MM, Bosman FT, et al. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 1985;6:26-30.
16. David WH, Michael LF, Ian WT, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
17. Robert CW, Fritz H, Leopold GK, et al. Caution on the use of lymphocytes as standards in the flow cytometric analysis of cultured cells. Cytometry 1982;2:370-373.
18. Matsson P. Analysis of chromosomes from human peripheral lymphocytes by flow cytometry. Cytometry 1981;1:369-372.